Dermapharm Holding SE (ETR:DMP)

Dermapharm Holding SE Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	225.93	203.41	121.31	158.72	151.02	161.41
Cash & Short-Term Investments	225.93	203.41	121.31	158.72	151.02	161.41
Cash Growth	96.16%	67.68%	-23.57%	5.10%	-6.44%	34.17%
Accounts Receivable	135.82	109.69	100.9	90.94	96.72	72.52
Other Receivables	1.84	1.84	1.17	0.15	0.04	0.34
Total Trade Receivables	137.67	111.53	102.07	91.08	96.76	72.86
Inventory	359.66	328.71	343.38	320.76	255.72	243.6
Other Current Assets	56.79	59.28	26.74	59.93	30.45	41.35
Total Current Assets	780.05	702.93	593.5	630.5	533.95	519.22
Net Property, Plant & Equipment	332.79	318.54	315.03	330.77	225.67	222.29
Other Intangible Assets	473.74	480.44	512.31	544.86	305.04	294.84
Goodwill	587.1	587.06	576.38	578.52	271.32	264.73
Long-Term Investments	32.95	32.81	20.67	23.61	35.36	54.16
Other Long-Term Assets	66.03	65.02	62.13	52.41	41.49	51.73
Total Assets	2,273	2,187	2,080	2,161	1,413	1,407

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	114.21	96.26	94.79	86.64	56.1	52.1
Accrued Expenses	19.28	19.68	23.39	27.3	24.93	18.68
Current Portion of Long-Term Debt	123.18	129.38	89.94	116.43	4.89	5.58
Other Current Liabilities	133.57	97.6	118.81	164.12	131.88	79.25
Total Current Liabilities	390.24	342.93	326.92	394.49	217.79	155.61
Long-Term Debt	916.28	922.91	889.68	963.96	511.56	574.72
Other Long-Term Liabilities	230.97	230.2	255.13	257.18	150.99	176.8
Total Long-Term Liabilities	1,147	1,153	1,145	1,221	662.55	751.52
Total Liabilities	1,537	1,496	1,472	1,616	880.35	907.14

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	53.84	53.84	53.84	53.84	53.84	53.84
Additional Paid-in Capital	100.79	100.79	100.79	100.79	100.79	100.79
Accumulated Other Comprehensive Income	23.12	23.83	16.6	17.35	21.6	4.73
Retained Earnings	561.11	515.91	433.19	367.22	355.36	337.95
Total Common Shareholders' Equity	738.86	694.38	604.42	539.21	531.59	497.32
Minority Interest	-3.69	-3.61	3.87	5.84	0.9	2.52
Shareholders' Equity	735.18	690.77	608.3	545.05	532.49	499.83
Total Liabilities & Equity	2,273	2,187	2,080	2,161	1,413	1,407

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1,039	1,052	979.61	1,080	516.45	580.3
Net Cash (Debt)	-813.54	-848.88	-858.3	-921.66	-365.43	-418.89
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-15.12	-15.77	-15.94	-17.12	-6.79	-7.78
Book Value	738.86	694.38	604.42	539.21	531.59	497.32
Book Value Per Share	13.73	12.90	11.23	10.02	9.87	9.24
Tangible Book Value	-321.99	-373.12	-484.28	-584.17	-44.77	-62.26
Tangible Book Value Per Share	-5.98	-6.93	-8.99	-10.85	-0.83	-1.16

Data Source: Fiscal.ai Last updated: May 13, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 24, 2026

Data Sources Report a data error